Annexon, Inc. (ANNX)
ANNX Stock Price Chart
Explore Annexon, Inc. interactive price chart. Choose custom timeframes to analyze ANNX price movements and trends.
ANNX Company Profile
Discover essential business fundamentals and corporate details for Annexon, Inc. (ANNX) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
24 Jul 2020
Employees
106.00
Website
https://www.annexonbio.comCEO
Douglas E. Love
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain- barré syndrome; Phase II trial in patients with warm autoimmune hemolytic anemia; and Phase II clinical trial for Huntington's disease and amyotrophic lateral sclerosis. The company is also developing ANX009 that is in Phase Ib trial in patients with lupus nephritis; and ANX007, which is in Phase II clinical trials to treat patients with geographic atrophy. In addition, it develops ANX105, an investigational monoclonal antibody targeting neurodegenerative indications; and ANX1502, an investigational oral small molecule for the treatment of certain autoimmune indications. The company was incorporated in 2011 and is headquartered in Brisbane, California.
ANNX Financial Timeline
Browse a chronological timeline of Annexon, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 11 May 2026
Upcoming earnings on 13 Nov 2025
EPS estimate is -$0.33.
Earnings released on 14 Aug 2025
EPS came in at -$0.34 surpassing the estimated -$0.36 by +5.56%.
Earnings released on 12 May 2025
EPS came in at -$0.37 falling short of the estimated -$0.30 by -23.33%.
Earnings released on 3 Mar 2025
EPS came in at -$0.33 falling short of the estimated -$0.28 by -17.86%.
Earnings released on 14 Nov 2024
EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%.
Earnings released on 12 Aug 2024
EPS came in at -$0.23 matching the estimated -$0.23.
Earnings released on 13 May 2024
EPS came in at -$0.21 surpassing the estimated -$0.32 by +34.38%.
Earnings released on 26 Mar 2024
EPS came in at -$0.36 surpassing the estimated -$0.45 by +20.00%, while revenue for the quarter reached $4.87M .
Earnings released on 13 Nov 2023
EPS came in at -$0.43 surpassing the estimated -$0.50 by +14.00%.
Earnings released on 7 Aug 2023
EPS came in at -$0.47 surpassing the estimated -$0.54 by +12.96%.
Earnings released on 8 May 2023
EPS came in at -$0.52 matching the estimated -$0.52.
Earnings released on 6 Mar 2023
EPS came in at -$0.48 surpassing the estimated -$0.52 by +7.69%.
Earnings released on 3 Nov 2022
EPS came in at -$0.51 surpassing the estimated -$0.87 by +41.38%.
Earnings released on 8 Aug 2022
EPS came in at -$0.96 falling short of the estimated -$0.94 by -2.13%.
Earnings released on 9 May 2022
EPS came in at -$0.92 surpassing the estimated -$1.00 by +8.00%.
Earnings released on 1 Mar 2022
EPS came in at -$0.97 falling short of the estimated -$0.90 by -7.78%.
Earnings released on 9 Nov 2021
EPS came in at -$0.93 falling short of the estimated -$0.88 by -5.68%.
Earnings released on 16 Aug 2021
EPS came in at -$0.82 falling short of the estimated -$0.68 by -20.59%.
Earnings released on 17 May 2021
EPS came in at -$0.68 falling short of the estimated -$0.60 by -13.33%.
Earnings released on 25 Mar 2021
EPS came in at -$0.61 falling short of the estimated -$0.42 by -45.24%.
Earnings released on 16 Nov 2020
EPS came in at -$0.77 falling short of the estimated -$0.34 by -126.47%.
ANNX Stock Performance
Access detailed ANNX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.